These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33979552)

  • 1. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery.
    Mohammadi M; Elahimehr Z; Mahboobian MM
    Curr Eye Res; 2021 Nov; 46(11):1646-1652. PubMed ID: 33979552
    [No Abstract]   [Full Text] [Related]  

  • 2. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.
    Mahboobian MM; Seyfoddin A; Aboofazeli R; Foroutan SM; Rupenthal ID
    Pharm Dev Technol; 2019 Jun; 24(5):600-606. PubMed ID: 30472913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation.
    Kassaee SN; Mahboobian MM
    Drug Deliv Transl Res; 2022 Jan; 12(1):229-239. PubMed ID: 33575973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    Suwannoi P; Chomnawang M; Sarisuta N; Reichl S; Müller-Goymann CC
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):743-752. PubMed ID: 29111864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A; Al-Kassas R
    Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
    Vadlapudi AD; Cholkar K; Vadlapatla RK; Mitra AK
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):49-58. PubMed ID: 24192229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability.
    Varela-Garcia A; Concheiro A; Alvarez-Lorenzo C
    Int J Pharm; 2018 Dec; 552(1-2):39-47. PubMed ID: 30253214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
    Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
    Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
    Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
    Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir.
    Seyfoddin A; Sherwin T; Patel DV; McGhee CN; Rupenthal ID; Taylor JA; Al-Kassas R
    Curr Drug Deliv; 2016; 13(6):923-34. PubMed ID: 26568139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
    El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
    Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability.
    Elkasabgy NA
    Int J Pharm; 2014 Jan; 460(1-2):33-44. PubMed ID: 24184217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir).
    Kumar R; Sinha VR
    AAPS PharmSciTech; 2017 Apr; 18(3):884-894. PubMed ID: 27368921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
    Law SL; Huang KJ; Chiang CH
    J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Ocular Irritation and Bioavailability of Voriconazole Loaded Microemulsion.
    Kumar R; Sinha VR
    Curr Drug Deliv; 2017; 14(5):718-724. PubMed ID: 27538459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
    Paul S; Kumar A; Yedurkar P; Sawant K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
    Pathak MK; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipid-based drug delivery systems for enhancing solubility of highly selective antiviral agent acyclovir.
    Kazi M; Al-Amri KA; Alanazi FK
    Pharm Dev Technol; 2017 May; 22(3):312-321. PubMed ID: 26458371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.